Gaining insight into benzodiazepine prescribing in General Practice in France: A data-based study

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Rosman, Sophia ^a,b,c   Marc, Le Vaillant ^a,b,c   Nathalie, Pelletier Fleury ^a,b,c  

^a CNRS   (France)

^b ÉCOLE DES HAUTES ÉTUDES EN SCIENCES SOCIALES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

AGE; AGED; ARTICLE; CLINICAL PRACTICE; ELECTRONIC MEDICAL RECORD; FEMALE; FRANCE; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; PRESCRIPTION; RISK; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS;

AGE FACTORS; AGED; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; DRUG PRESCRIPTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; FRANCE; GENERAL PRACTICE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS;

EID: 79955757518     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-28     Document Type: Article

References (29)

1. Consensus development conference statement: the treatment of sleep disorders of older people. National Institute of Health, Sleep 1991 14 169 77 1866532
2. Guidance on the use of Zaleplon, Zolpidem and Zopiclone for the short term management of insomnia. National Institute for Clinical Excellence, NICE London 2004 http://www.nice.org.uk/TA077guidance (Accessed January 13, 2011)
3. Health Insurance Online, Medications reimbursed by the General Insurance from 2004 to 2008. Health Insurance Online 2009 http://www.ameli.fr/l-assurance- maladie/statistiques-et-publications/donnees-statistiques/medic-am-generic-am- biolam-lpp-am/medic-am-2004-2008.php (Accessed January 13, 2011)
4. Guidance on the use of benzodiazepines and z-drugs in elderly patient (in French: modalities d'arrt des benzodiazepines et medicaments apparentés chez le patient gé) Haute Autorité de Santé (in French: Haute Autorité de Santé), Paris. 2007 http://www.has-sante.fr/ portail/upload/docs/application/pdf/synthese-bzd-version-finale-2008.pdf
5. M Briot, Report on the proper use of psychotropic medications Report (in French: Rapport sur le bon usage des médicaments psychotropes) The Parliamentary Office of Health Policy (in French: L'Office parlementaire d'évaluation des politiques de santé), Paris; 2006 http://www.senat.fr/notice-rapport/2005/r05-422-notice.html (Accessed January 13, 2011)
6. Psychotropic drugs: consumption and prescribing practices in France (in French: Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine). J Lecadet P Vidal B Baris N Vallier P Fender H Allemand the Médipath group, Revue Médicale de l'assurance Maladie 2003 2 75 84 19594077
7. Observatory of general practice (in French: Observatoire de médecine générale). French Society of General Practice, SFMG, Issy les Moulineaux 2006 http://omg.sfmg.org (Accessed January 13, 2011)
8. st of January 1999 (in French: Les médecins par spécialité inscrits au repertoire ADELI au 1er Janvier 1999). Etudes et Statistiques 1999 12
9. Dictionary of Consultation Results. Révision 2003-2004 (in French: Dictionnaire des Résultats de Consultation). P Ferru O Kandel, Doc Rech Med Gen Société Française de Médecine Générale, Paris 2004 62 3 54
10. Regression analysis for correlated data. L Kung-Yee S Zegers, Annu Rev Pub Health 1993 14 43 68 10.1146/annurev.pu.14.050193.000355
11. SAS/Stat. User's guide: release 8 SAS Institute, Cary (NC) 1 2001 21563287
12. Benzodiazepine prescribing in general practice: dispelling some myths. A Mant R Mattick S de Burgh N Donnelly W Hall, Fam Pract 1995 12 1 37 43 10.1093/fampra/12.1.37 7665039
13. Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. J Straand KS Rokstad, A report from the Møre & Romsdal Prescription Study Fam Pract 1999 16 4 380 8
14. Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. A Berger M Mychaskiw E Dukes J Edelsberg G Oster, BMC Geriatr 2009 9 31 10.1186/1471-2318-9-31 19635161
15. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. HY Lai SJ Hwang YC Chen TJ Chen MH Lin LK Chen, Clin Ther 2009 31 8 1859 70 10.1016/j.clinthera.2009.08.023 19808145
16. Correlates of benzodiazepine use in individuals with insomnia. C Morin L Bélanger F Bernier, Sleep Med 2004 5 457 462 10.1016/j.sleep.2004.04.001 15341890 (Pubitemid 39194055)
17. Psychotropic drugs and the elderly: a socialisation of consumption (in French: Médicaments psychotropes et personnes gées: une socialization de la consommation). J Collin, Revue Québecoise de psychologie 2001 22 2 1 24
18. Construction of rationality: physicians facing the prescription of psychotropic drugs to elderly persons (in French: La construction d'une rationalité: les médecins face la prescription de psychotropes aux personnes gées). J Collin N Damestoy R Lalande, Sciences Sociales et Santé 1999 17 2 31 50 10.3406/sosan.1999.1458
19. Sex differences among recipients of benzodiazepines in Dutch general practice. F Van de Waals J Mohrs M Foets, BMJ 1993 307 363 366 10.1136/bmj.307.6900.363 8104066 (Pubitemid 23224196)
20. Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. K Johnell GR Weitoft J Fastbom, Ann Pharmacother 2009 43 7 1233 8 10.1345/aph.1M147 19584395
21. Evil necessity? The meaning of benzo use for women from a general practice. J Gabe S Lipshitz-Phillips, Sociology of Health and Illness 1982 4 2 201 10 10.1111/1467-9566.ep11339945
22. The diagnosis and management of benzodiazepine dependence. H Ashton, Curr Opin Psychiatry 2005 18 249 255 10.1097/01.yco.0000165594.60434.84 16639148 (Pubitemid 40586107)
23. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. J Parr D Kavanagh L Cahil G Mitchell R McD Young, Addiction 2009 104 1 13 24 10.1111/j.1360-0443.2008.02364.x 19133911
24. The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder. M Smolders M Laurant E van Rijswijk J Mulder J Braspenning P Verhaak M Wensing R Grol, Fam Pract 2007 24 6 538 46 10.1093/fampra/cmm062 18003604
25. Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population. MG Terzano L Parrino F Cirignotta L Ferini-Strambi, Sleep Med 2004 5 67 75 10.1016/j.sleep.2003.09.006 14725829 (Pubitemid 38145714)
26. Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway. B Sivertsen IH Nordhus B Bjorvatn S Pallesen, J Sleep Res 2010 19 1 Pt 1 36 41 19732316
27. Medical consultation: the influence of the income and the private insurance. G Piaser D Raynaud, Revue Economique 2002 53 1 113 133
28. GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. AN Siriwardena Z Qureshi S Gibson S Collier M Latham, Br J Gen Pract 2006 56 533 964 7 17132386 (Pubitemid 44941796)
29. Benzodiazepine prescribing: lessons from interprofessional dialogue. C Johnson B Baxter R Brough J Buchanan, Aust Fam Physician 2007 36 4 245 6 17392937